A Comparison of TearCare and Lipiflow Systems in Reducing Dry Eye Disease Symptoms Associated with Meibomian Gland Disease

PURPOSE: To compare TearCare and Lipiflow systems in the ability to reduce the symptoms of dry eye disease (DED) associated with meibomian gland dysfunction (MGD). METHODS: In this multicenter, masked, randomized-controlled trial, 235 subjects received a single TearCare treatment (n = 115) or a sing...

Descripción completa

Detalles Bibliográficos
Autores principales: Holland, Edward J, Loh, Jennifer, Bloomenstein, Marc, Thompson, Vance, Wirta, David, Dhamdhere, Kavita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440678/
https://www.ncbi.nlm.nih.gov/pubmed/36065356
http://dx.doi.org/10.2147/OPTH.S368319

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440678/
https://www.ncbi.nlm.nih.gov/pubmed/36065356
http://dx.doi.org/10.2147/OPTH.S368319

Ejemplares similares